Literature DB >> 24447812

Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells.

Lin Tang1, Hui Li2, Rong Gou2, Genyang Cheng2, Yuanyuan Guo2, Yudong Fang2, Fengmei Chen2.   

Abstract

OBJECTIVE: The pathogenesis of interstitial fibrosis in diabetic nephropathy (DN) is an intractable problem without good therapy. Emerging evidence suggests that epithelial-mesenchymal transition (EMT) is an important mechanism for tubular epithelial cells undergoing profibrotic change in DN. Endothelin-1 (ET-1) is an important cytokine which can cause fibrogenesis and is reportedly involved in DN. However, the role of ET-1 in EMT in DN is unknown. The present study was designed to investigate the role of ET-1 in high glucose-induced EMT and the signaling pathway mediating the effect of ET-1 in renal tubular cells.
METHOD: Tubular epithelial cells (NRK52E) were treated with normal glucose (d-glucose 5.6mmol/L, NG), high glucose (30mmol/L, HG), high osmotic (d-glucose 5.6mmol/L+d-mannitol 24.4mmol/L), HG+ETA antagonist BQ123 (2μg/ml), ET-1, ET-1+ hypoxia inducible factor (HIF)-1α siRNA, CoCl2 (100μmol/L), CoCl2+HIF-1α siRNA or CoCl2+BQ123. The supernatant level of ET-1 was measured by ELISA and the expression of vimentin, E-cadherin and HIF-1α was detected by RT-PCR and western blot. RESULT: The ET-1 level increased markedly in the supernatant of NRK52E incubated with HG. In NRK52E induced with HG or ET-1, the expression of vimentin was upregulated, whereas the expression of E-cadherin was downregulated. BQ123 attenuated HG- and CoCl2-induced EMT while HIF-1α siRNA did not affect ET-1 induced EMT.
CONCLUSIONS: High glucose induced ET-1 production that mediated the EMT induced by high glucose in renal tubular epithelial cells, and HIF-1α acted as the upstream signal to regulate ET-1.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Fibrosis; Hypoxia inducible factor

Mesh:

Substances:

Year:  2014        PMID: 24447812     DOI: 10.1016/j.diabres.2013.12.021

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.

Authors:  Stephanie Franzén; Fredrik Palm
Journal:  Diabetologia       Date:  2015-07-15       Impact factor: 10.122

Review 2.  The Nax (SCN7A) channel: an atypical regulator of tissue homeostasis and disease.

Authors:  David Dolivo; Adrian Rodrigues; Lauren Sun; Yingxing Li; Chun Hou; Robert Galiano; Seok Jong Hong; Thomas Mustoe
Journal:  Cell Mol Life Sci       Date:  2021-06-08       Impact factor: 9.261

3.  EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

Authors:  Na Liu; Li Wang; Tao Yang; Chongxiang Xiong; Liuqing Xu; Yingfeng Shi; Wenfang Bao; Y Eugene Chin; Shi-Bin Cheng; Haidong Yan; Andong Qiu; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Modulation of the cancer cell transcriptome by culture media formulations and cell density.

Authors:  Seung Wook Kim; Sun-Jin Kim; Robert R Langley; Isaiah J Fidler
Journal:  Int J Oncol       Date:  2015-03-17       Impact factor: 5.650

Review 5.  Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease.

Authors:  Jing Liu; Qingqing Wei; Chunyuan Guo; Guie Dong; Yu Liu; Chengyuan Tang; Zheng Dong
Journal:  Int J Mol Sci       Date:  2017-04-30       Impact factor: 5.923

6.  ET-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis.

Authors:  Huey-En Tzeng; Chih-Hsin Tang; Chun-Hao Tsai; Chih-Hui Chiu; Min-Huan Wu; Yun Yen
Journal:  Onco Targets Ther       Date:  2021-10-06       Impact factor: 4.147

Review 7.  Endothelin Blockade in Diabetic Kidney Disease.

Authors:  Lidia Anguiano; Marta Riera; Julio Pascual; María José Soler
Journal:  J Clin Med       Date:  2015-05-25       Impact factor: 4.241

8.  Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.

Authors:  Teresa M Seccia; Brasilina Caroccia; Francesca Gioco; Maria Piazza; Valentina Buccella; Diego Guidolin; Eugenia Guerzoni; Barbara Montini; Lucia Petrelli; Elisa Pagnin; Verdiana Ravarotto; Anna S Belloni; Lorenzo A Calò; Gian Paolo Rossi
Journal:  J Am Heart Assoc       Date:  2016-07-21       Impact factor: 5.501

9.  Endothelin receptors in renal interstitial cells do not contribute to the development of fibrosis during experimental kidney disease.

Authors:  Thomas H Neder; Julia Schrankl; Michaela A A Fuchs; Katharina A E Broeker; Charlotte Wagner
Journal:  Pflugers Arch       Date:  2021-08-06       Impact factor: 3.657

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.